blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1585767

EP1585767 - SYNTHETIC ANTIBODY PHAGE LIBRARIES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.07.2010
Database last updated on 12.07.2024
Most recent event   Tooltip09.07.2010Application deemed to be withdrawnpublished on 11.08.2010  [2010/32]
Applicant(s)For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
[N/P]
Former [2005/42]For all designated states
GENENTECH, INC.
1 DNA Way
South San Francisco, CA 94080-4990 / US
Inventor(s)01 / BOND, Christopher, J.
2868 22nd Street
San Francisco, CA 94110 / US
 [2005/42]
Representative(s)Harding, Charles Thomas
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2005/42]Harding, Charles Thomas
D Young & Co 120 Holborn
London EC1N 2DY / GB
Application number, filing date04702925.116.01.2004
[2005/42]
WO2004US01097
Priority number, dateUS20030441059P16.01.2003         Original published format: US 441059 P
US20030488610P18.07.2003         Original published format: US 488610 P
US20030510314P08.10.2003         Original published format: US 510314 P
[2005/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004065416
Date:05.08.2004
Language:EN
[2004/32]
Type: A2 Application without search report 
No.:EP1585767
Date:19.10.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 05.08.2004 takes the place of the publication of the European patent application.
[2005/42]
Search report(s)International search report - published on:EP10.02.2005
ClassificationIPC:C07K16/00, C12N15/13, C12N15/85, C12N5/10
[2005/42]
CPC:
C07K16/005 (EP,US); C07K2317/22 (EP,US); C07K2317/54 (EP,US);
C07K2317/55 (EP,US); C07K2317/56 (EP,US); C07K2317/565 (EP,US);
C07K2317/567 (EP,US); C07K2317/569 (EP,US); C07K2319/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/42]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:PHAGENBIBLIOTHEK VON SYNTHETISCHEN ANTIKÖRPERN[2005/42]
English:SYNTHETIC ANTIBODY PHAGE LIBRARIES[2005/42]
French:BANQUES DE PHAGES ANTICORPS SYNTHETIQUES[2005/42]
Entry into regional phase10.08.2005National basic fee paid 
10.08.2005Designation fee(s) paid 
10.08.2005Examination fee paid 
Examination procedure10.08.2005Examination requested  [2005/42]
02.11.2007Despatch of a communication from the examining division (Time limit: M06)
09.05.2008Reply to a communication from the examining division
12.10.2009Despatch of a communication from the examining division (Time limit: M04)
23.02.2010Application deemed to be withdrawn, date of legal effect  [2010/32]
29.03.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/32]
Fees paidRenewal fee
12.01.2006Renewal fee patent year 03
12.01.2007Renewal fee patent year 04
14.01.2008Renewal fee patent year 05
14.01.2009Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.01.201007   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO0077194  (GENENTECH INC [US]) [X] 59,60,66-69,77-83,85-89,92-95,105,106,112-114 * page 9, line 22 - page 10, line 4 * * examples 4-6 * * claim - *;
 [X]WO0024884  (UNILEVER PLC [GB], et al) [X] 105,112,114 * figure 2 *;
 [A]WO0190190  (CA NAT RESEARCH COUNCIL [CA], et al) [A] 59-114 * claim - *;
 [X]  - TANHA J ET AL, "Optimal design features of camelized human single-domain antibody libraries", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, (20010706), vol. 276, no. 27, ISSN 0021-9258, pages 24774 - 24780, XP002283749 [X] 59-61,67,77-83,85-89 * tables II,III * * page 24779, column L, paragraph 3 *

DOI:   http://dx.doi.org/10.1074/jbc.M100770200
 [X]  - ARBABI GHAHROUDI M ET AL, "Selection and identification of single domain antibody fragments from camel heavy-chain antibodies", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (19970915), vol. 414, no. 3, ISSN 0014-5793, pages 521 - 526, XP004261105 [X] 105,106,112-114 * page 521, column R, paragraph 3 * * page 522, column L, paragraphs 2,3 * * figure 2 *

DOI:   http://dx.doi.org/10.1016/S0014-5793(97)01062-4
 [X]  - HARMSEN M M ET AL, "Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features", MOLECULAR IMMUNOLOGY, ELMSFORD, NY, US, (200008), vol. 37, no. 10, ISSN 0161-5890, pages 579 - 590, XP002244235 [X] 59,111 * fig.1 Accession number: AJ237368, 005523 * * page 587, column L, paragraph 3 - page 588, column R, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/S0161-5890(00)00081-X
 [A]  - MUYLDERMANS S, "SINGLE DOMAIN CAMEL ANTIBODIES: CURRENT STATUS", REVIEWS IN MOLECULAR BIOTECHNOLOGY, ELSEVIER, AMSTERDAM,, NL, (200106), vol. 74, no. 4, ISSN 1389-0352, pages 277 - 302, XP001057480 [A] 59-114 * Section 2.5.3 *

DOI:   http://dx.doi.org/10.1016/S1389-0352(01)00021-6
 [A]  - VAJDOS F F ET AL, "Comprehensive Functional Maps of the Antigen-binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (20020705), vol. 320, no. 2, ISSN 0022-2836, pages 415 - 428, XP004449739 [A] 59-114 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0022-2836(02)00264-4
 [T]  - BOND C J ET AL, "Contributions of CDR3 to VHH Domain Stability and the Design of Monobody Scaffolds for Naive Antibody Libraries", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (20030919), vol. 332, no. 3, ISSN 0022-2836, pages 643 - 655, XP004454278 [T] 105,112,114 * page 644, column R, paragraph L - page 645, column L, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0022-2836(03)00967-7
 [T]  - SIDHU S S ET AL, "Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (20040423), vol. 338, no. 2, ISSN 0022-2836, pages 299 - 310, XP004500301 [T] 59-114 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jmb.2004.02.050
 [T]  - PRESTA L G ET AL, "HUMANIZATION OF AN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOCLONAL ANTIBODY FOR THE THERAPY OF SOLID TUMORS AND OTHER DISORDERS", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, (19971015), vol. 57, ISSN 0008-5472, pages 4593 - 4599, XP002926854 [T] 59-114 * the whole document *
Examination   - KRUIF DE J. ET AL, "SELECTION AND APPLICATION OF HUMAN SINGLE CHAIN FV ANTIBODY FRAGMENTS FROM A SEMI-SYNTHETIC PHAGE ANTIBODY DISPLEY LIBRARY WITHDESIGNED CDR3 REGIONS", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (19950421), vol. 248, no. 1, pages 97 - 105, XP000646544

DOI:   http://dx.doi.org/10.1006/jmbi.1995.0204
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.